Essex Pharma Development GmbH specialties include pharmaceutical analytics.
Essex Pharma Development GmbH specialties include pharmaceutical analytics (to include large scale stability programs), as well as bioanalytics. In 2008, the development institute – located in Waltrop near Dortmund – was acquired by Merck & Co as part of the acquisition of the former Schering-Plough Corporation. Outside of the USA and Canada, the new Merck & Co. Inc. takes the corporate name “MSD.” The corporation is one of the world’s largest providers of innovative medications, vaccines, biological therapeutic preparations, consumer health products and veterinarian health products.